CoChat

Effects of ferrous sulphate and non‐ionic iron–polymaltose complex on markers of oxidative tissue damage in patients with inflammatory bowel disease

ERICHSEN, K., ULVIK, R. J., GRIMSTAD, T., BERSTAD, A., BERGE, R. K., HAUSKEN, T. · 2005 · Alimentary Pharmacology & Therapeutics
Cited by 70

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Summary: Background : Iron deficiency is a common complication of inflammatory bowel disease. Oral iron therapy may reinforce intestinal tissue injury by catalyzing production of reactive oxygen species. Aim : To compare the effects of ferrous sulphate and non‐ionic iron–polymaltose complex on markers of oxidative tissue damage and clinical disease activity in patients with inflammatory bowel disease. Methods : Forty‐one patients with inflammatory bowel disease and iron deficiency were randomized to treatment with ferrous sulphate 100 mg twice a day or iron–polymaltose complex 200 mg once a day for 14 days. Results : Following ferrous sulphate, plasma malondialdehyde increased (P = 0.02), while urine 8‐isoprostaglandin F 2 α and plasma antioxidants did not change significantly. Iron–polymaltose complex did not change plasma malondialdehyde, urine 8‐isoprostaglandin F 2 α or plasma antioxidants. Comparing the two treatments, changes in plasma malondialdehyde tended to differ (P = 0.08), while urine 8‐isoprostaglandin F 2 α and plasma antioxidants did not differ. Neither ferrous sulphate nor iron–polymaltose complex altered clinical disease activity indices. Conclusions : Ferrous sulphate increased plasma malondialdehyde, a marker of lipid peroxidation. Comparing treatment with ferrous sulphate and iron–polymaltose complex, changes in plasma malondialdehyde tended to differ. Clinical disease activity was unchanged after both treatments.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2036.2005.02652.x

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 70

Metadata

Authors
ERICHSEN, K., ULVIK, R. J., GRIMSTAD, T., BERSTAD, A., BERGE, R. K., & HAUSKEN, T.
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
2005-10-14
Volume
22
Issue
9
Pages
831-838
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W2019440184
Cited by
70
References
3
FWCI
1.51
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of ferrous sulphate and non‐ionic iron–polymaltose complex on markers of oxidative tissue damage in patients with inflammatory bowel disease. https://app.cochat.ai/papers/10.1111/j.1365-2036.2005.02652.x
The paper
ERICHSEN, K., ULVIK, R. J., GRIMSTAD, T., BERSTAD, A., BERGE, R. K., & HAUSKEN, T. (2005). Effects of ferrous sulphate and non‐ionic iron–polymaltose complex on markers of oxidative tissue damage in patients with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/j.1365-2036.2005.02652.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.